: $Actelis Networks(ASNS)$ 中概退潮,玩你们俩兄弟够了,神经病一样的庄,疯狂的手法查看全文
usbiostock2018-06-28 19:46
$Arsanis, Inc.(ASNS)$ 公司宣布ASN100预防金黄色葡萄球菌肺炎临床2期试验未能达到主要终点,公司将终止该药的研发。公司重点将放在ASN500,用于预防呼吸道合胞病毒感染。查看全文
美股医药Z博士2017-12-12 11:33
$Arsanis, Inc.(ASNS)$ 来推荐一只IPO不久的股票,喜欢短线的朋友可以关注。公司具有很多极具潜力的单抗抗生素药物,目前股价已跌破发行价。今日两大投行提高它的评级,并给出23的目标价,结果有意思的是股价居然-12%。是个不错的短线机会,第一个目标价16左右。查看全文
$Actelis Networks(ASNS)$ 8-A12B Registration of securities [Section 12(b)] Accession Number: 0001213900-22-023871 Act: 34 Size: 14 KB 网页链接
$Actelis Networks(ASNS)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001213900-22-023084 Act: 34 Size: 10 MB 网页链接
$Actelis Networks(ASNS)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-22-023064 Act: 33 Size: 6 MB 网页链接
$Arsanis(ASNS)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-22-020064 Act: 33 Size: 7 MB 网页链接
$Arsanis(ASNS)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-04-26 AccNo: 0001193125-19-122305 Size: 57 KB 网页链接
$Arsanis(ASNS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-04-23 AccNo: 0000921895-19-001144 Size: 227 KB 网页链接
$Arsanis(ASNS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-04-22 AccNo: 0000929638-19-000464 Size: 184 KB 网页链接
$Arsanis(ASNS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-04-19 AccNo: 0000947871-19-000298 Size: 104 KB 网页链接
$Arsanis(ASNS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-04-16 AccNo: 0001193805-19-000363 Size: 102 KB 网页链接
$Arsanis(ASNS)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-04-15 AccNo: 0001193125-19-106612 Size: 740 KB 网页链接